$1.490
-0.039 (-2.61%)At close
SINT News
SINT Events
Selling Stockholders Plan to Sell 1.27M Shares of Common Stock
This filing relates to the offer and sale from time to time by the selling stockholders of up to 1.27M shares of common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Sintx Technologies Files to Sell 5.82M Shares of Common Stock
Sintx Technologies files to sell 5.82M shares of common stock for holders
Sintx Technologies Secures Over $3.2M in Orders
Sintx Technologies announced that it has received purchase orders from multiple contract manufacturing customers with an aggregate value exceeding $3.2M for the production of advanced ceramic components.
SINTX Completes First-in-Human Surgery, Enters Global Orthopedic Market
The company states: "SINTX Technologies announced the successful completion of the first-in-human surgical procedure utilizing its FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System, marking a major clinical and commercial milestone in the Company's expansion into the global orthopedic device market. The procedure represents SINTX's entry into the foot and ankle reconstruction segment, a significant and growing category within the multi-billion-dollar orthopedic implant market, and underscores the Company's strategy to commercialize its proprietary silicon nitride biomaterial platform across multiple surgical applications."
Sintx Technologies Appoints Ryan Elmore as President
Sintx Technologies announced the appointment of Ryan Elmore as President of SINTX Technologies, effective March 16, 2026. Elmore most recently served as Core Business Director at Invibio, a division of Victrex plc.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.